Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Influence of Cognitive Function on Speech and Articulation Rate in Multiple Sclerosis.
Iron oxide magnetic nanoparticles highlight early involvement of the choroid plexus in central nervous system inflammation.
The Gender Gap in Multiple Sclerosis: Intersection of Science and Society.
Myelin morphology and axon pathology in demyelination during experimental autoimmune encephalomyelitis.
Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination.
[Diagnosis and treatment of neuromyelitis optica.]
Quantitative oxygen extraction fraction from 7-Tesla MRI phase: reproducibility and application in multiple sclerosis.
The oncoprotein and transcriptional regulator bcl-3 governs plasticity and pathogenicity of autoimmune T cells.
Age-related changes in spleen of Dark Agouti rats immunized for experimental autoimmune encephalomyelitis.
'You are just left to get on with it': qualitative study of patient and carer experiences of the transition to secondary progressive multiple sclerosis.
Aquaporin-4 antibody-positive myelitis initially biopsied for suspected spinal cord tumors: Diagnostic considerations.
Autoantibodies and Sjogren's Syndrome in Multiple Sclerosis, a Reappraisal.
Recall strategies for the verbal fluency test in patients with multiple sclerosis.
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool.
Which is the goal of cognitive rehabilitation in multiple sclerosis: the improvement of cognitive performance or the perception of cognitive deficits?
Remote control-triggering of brain autoimmune disease in the gut.
Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy.
Therapeutic effects of nonerythropoietic erythropoietin analog ARA290 in experimental autoimmune encephalomyelitis rat.
Immunological Mechanism of Action and Clinical Profile of Disease-Modifying Treatments in Multiple Sclerosis.
Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis.
Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis-Reply.
Novel Inhibitors of Protein Arginine Deiminase with Potential Activity in Multiple Sclerosis Animal Model.
Ambulation and multiple sclerosis.
Stride-Time Variability and Fall Risk in Persons with Multiple Sclerosis.
The MiRNA Journey from Theory to Practice as a CNS Biomarker.
Pages
« first
‹ previous
…
470
471
472
473
474
475
476
477
478
…
next ›
last »